Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia

被引:324
作者
Mandriota, SJ [1 ]
Pepper, MS [1 ]
机构
[1] Univ Geneva, Med Ctr, Dept Morphol, CH-1211 Geneva 4, Switzerland
关键词
angiopoietin-2; angiogenesis; hypoxia; cytokine; vascular remodeling;
D O I
10.1161/01.RES.83.8.852
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiopoietin-2 (Ang2) is a ligand for the endothelial cell tyrosine kinase receptor Tie2 and counteracts blood vessel maturation/stability mediated by angiopoietin-1 (Ang1), the other known ligand of Tie2. Using degenerate oligonucleotides and reverse transcriptase-polymerase chain reaction, we have screened bovine microvascular endothelial (BME), aortic, lymphatic, pulmonary artery, and transformed fetal aortic endothelial cells, as well as rat smooth muscle cells for Ang1 and Ang2 expression. Except for high Ang2 mRNA levels found in BME cells, none of the endothelial cell types studied expressed appreciable levels of Ang1 or Ang2 mRNAs, whereas smooth muscle cells expressed both Ang1 and Ang2. BME cell Ang2 mRNA levels were increased by vascular endothelial growth factor (1.9- to 2.9-fold), basic fibroblast growth factor (1.6- to 2-fold), both cytokines in combination (2.9- to 4-fold), and hypoxia (3.1- to 5.6-fold) and were decreased by Ang1 (31% to 70%) or transforming growth factor-beta(1) (64% to 81%). Ang2 also decreased (60% to 82%) BME cell Ang2 mRNA. mRNA levels for the Tie1 or Tie2 receptors were only slightly modulated under the conditions described above. These findings suggest that the angiogenic effect of a number of regulators may be achieved in part through the regulation of an autocrine loop of Ang2 activity in microvascular endothelial cells.
引用
收藏
页码:852 / 859
页数:8
相关论文
共 26 条
[11]   Signaling vascular morphogenesis and maintenance [J].
Hanahan, D .
SCIENCE, 1997, 277 (5322) :48-50
[12]   Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J].
Maisonpierre, PC ;
Suri, C ;
Jones, PF ;
Bartunkova, S ;
Wiegand, S ;
Radziejewski, C ;
Compton, D ;
McClain, J ;
Aldrich, TH ;
Papadopoulos, N ;
Daly, TJ ;
Davis, S ;
Sato, TN ;
Yancopoulos, GD .
SCIENCE, 1997, 277 (5322) :55-60
[13]   VASCULAR ENDOTHELIAL GROWTH-FACTOR INCREASES UROKINASE RECEPTOR EXPRESSION IN VASCULAR ENDOTHELIAL-CELLS [J].
MANDRIOTA, SJ ;
SEGHEZZI, G ;
VASSALLI, JD ;
FERRARA, N ;
WASI, S ;
MAZZIERI, R ;
MIGNATTI, P ;
PEPPER, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9709-9716
[14]   PHORBOL ESTERS INDUCE ANGIOGENESIS INVITRO FROM LARGE-VESSEL ENDOTHELIAL-CELLS [J].
MONTESANO, R ;
ORCI, L .
JOURNAL OF CELLULAR PHYSIOLOGY, 1987, 130 (02) :284-291
[15]  
Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2
[16]   COUPLING AND CONNEXIN-43 EXPRESSION IN MICROVASCULAR AND LARGE VESSEL ENDOTHELIAL-CELLS [J].
PEPPER, MS ;
MONTESANO, R ;
ELAOUMARI, A ;
GROS, D ;
ORCI, L ;
MEDA, P .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :C1246-C1257
[17]   IN-VITRO ANGIOGENIC AND PROTEOLYTIC PROPERTIES OF BOVINE LYMPHATIC ENDOTHELIAL-CELLS [J].
PEPPER, MS ;
WASI, S ;
FERRARA, N ;
ORCI, L ;
MONTESANO, R .
EXPERIMENTAL CELL RESEARCH, 1994, 210 (02) :298-305
[18]   Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells [J].
Pepper, MS ;
Mandriota, SJ .
EXPERIMENTAL CELL RESEARCH, 1998, 241 (02) :414-425
[19]  
Pepper MS, 1996, CURR TOP MICROBIOL, V213, P31
[20]   MODULATION OF HEPATOCYTE GROWTH-FACTOR AND C-MET IN THE RAT MAMMARY-GLAND DURING PREGNANCY, LACTATION, AND INVOLUTION [J].
PEPPER, MS ;
SORIANO, JV ;
MENOUD, PA ;
SAPPINO, AP ;
ORCI, L ;
MONTESANO, R .
EXPERIMENTAL CELL RESEARCH, 1995, 219 (01) :204-210